Upsher-Smith Launches Fluvoxamine Maleate Tablets


Upsher-Smith has launched fluvoxamine maleate tablets in 25 mg, 50 mg, and 100 mg strengths.

Upsher-Smith Laboratories, LLC (Upsher-Smith) has announced the launch of fluvoxamine maleate tablets in 25 mg, 50 mg and 100 mg strengths. The fluvoxamine tablet market had U.S. sales of approximately $28 million for the 12 months ending September 2019, according to IQVIA.


Upsher-Smith Launches Fluvoxamine Maleate Tablets. PR Newswire. Published January 10, 2020. Accessed January 14, 2020.

Related Videos
selling mental health medication to man at pharmacy | Image Credit: Syda Productions -
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk -
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg -
Image credit: |
Medical team -- Image credit: Flamingo Images |
© 2024 MJH Life Sciences

All rights reserved.